206 related articles for article (PubMed ID: 16932322)
21. Epilogue: The future of Laron syndrome - The need for changes.
Laron Z
Growth Horm IGF Res; 2016 Jun; 28():79-80. PubMed ID: 26283274
[No Abstract] [Full Text] [Related]
22. [Short stature investigation: clinical, laboratorial and genetic aspects concerning the growth hormone insensitivity (GHI)].
Jorge AA
Arq Bras Endocrinol Metabol; 2008 Aug; 52(6):1056-65. PubMed ID: 18820818
[TBL] [Abstract][Full Text] [Related]
23. For debate: did the small-bodied hominis from flores (Indonesia) suffer from a molecular defect in the growth hormone receptor gene (Laron syndrome)?
Laron Z; Kornreich L; Hershkovitz I
Pediatr Endocrinol Rev; 2006 Jun; 3(4):345-6. PubMed ID: 16816802
[No Abstract] [Full Text] [Related]
24. Growth hormone insensitivity resulting from post-GH receptor defects.
Rosenfeld RG; Kofoed E; Little B; Woods K; Buckway C; Pratt K; Hwa V
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S35-8. PubMed ID: 15135774
[TBL] [Abstract][Full Text] [Related]
25. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
26. Clinical, Endocrine, and Molecular Genetic Analysis of a Large Cohort of Saudi Arabian Patients with Laron Syndrome.
Al-Ashwal AA; Al-Sagheir A; Ramzan K; Al-Owain M; Allam R; Qari A; Al-Numair NS; Imtiaz F
Horm Res Paediatr; 2017; 88(2):119-126. PubMed ID: 28743110
[TBL] [Abstract][Full Text] [Related]
27. The chronicle of growth hormone receptor deficiency (Laron syndrome).
Rosenbloom AL
Acta Paediatr Suppl; 1992 Sep; 383():117-20. PubMed ID: 1458005
[No Abstract] [Full Text] [Related]
28. Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome.
Hui HN; Metherell LA; Ng KL; Savage MO; Camacho-Hübner C; Clark AJ
J Pediatr Endocrinol Metab; 2005 Feb; 18(2):209-13. PubMed ID: 15751611
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?
Rosenbloom AL
J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604
[No Abstract] [Full Text] [Related]
30. Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
Backeljauw P
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():853-6. PubMed ID: 18438329
[No Abstract] [Full Text] [Related]
31. Statement 6: patients who are unresponsive to GH therapy should be given a trial of IGF-I.
Hardin DS
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():857-60. PubMed ID: 18438330
[No Abstract] [Full Text] [Related]
32. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.
Laron Z; Kauli R
Growth Horm IGF Res; 2016 Jun; 28():53-6. PubMed ID: 26307357
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of the pedigrees and molecular defects of the GH-receptor gene in the Israeli cohort of patients with Laron syndrome.
Shevah O; Laron Z
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():489-97. PubMed ID: 17551471
[TBL] [Abstract][Full Text] [Related]
34. [Laron syndrome by loss of functions of growth hormone receptor].
Kaji H
Nihon Rinsho; 2002 Feb; 60(2):306-12. PubMed ID: 11857918
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel mutation in the human growth hormone receptor gene (GHR) in a patient with Laron syndrome.
Gennero I; Edouard T; Rashad M; Bieth E; Conte-Aurio F; Marin F; Tauber M; Salles JP; El Kholy M
J Pediatr Endocrinol Metab; 2007 Jul; 20(7):825-31. PubMed ID: 17849745
[TBL] [Abstract][Full Text] [Related]
36. Insulinlike growth factor I affects ocular development: a study of untreated and treated patients with Laron syndrome.
Bourla DH; Laron Z; Snir M; Lilos P; Weinberger D; Axer-Siegel R
Ophthalmology; 2006 Jul; 113(7):1197.e1-5. PubMed ID: 16815402
[TBL] [Abstract][Full Text] [Related]
37. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation.
Bernasconi A; Marino R; Ribas A; Rossi J; Ciaccio M; Oleastro M; Ornani A; Paz R; Rivarola MA; Zelazko M; Belgorosky A
Pediatrics; 2006 Nov; 118(5):e1584-92. PubMed ID: 17030597
[TBL] [Abstract][Full Text] [Related]
38. Effects of growth hormone (GH) and insulin-like growth factor-I therapy in patients with gene defects in the GH axis.
Riedl S; Frisch H
J Pediatr Endocrinol Metab; 2006 Mar; 19(3):229-36. PubMed ID: 16607923
[TBL] [Abstract][Full Text] [Related]
39. First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model.
Sia KC; Gan SU; Mohd Rodhi SH; Fu ZY; Kopchick JJ; Waters MJ; Lee KO
Gene Ther; 2022 Jun; 29(6):346-356. PubMed ID: 35105948
[TBL] [Abstract][Full Text] [Related]
40. Cloning and characterization of cDNAs for hormones and/or receptors of growth hormone, insulin-like growth factor-I, thyroid hormone, and corticosteroid and the gender-, tissue-, and developmental-specific expression of their mRNA transcripts in fathead minnow (Pimephales promelas).
Filby AL; Tyler CR
Gen Comp Endocrinol; 2007 Jan; 150(1):151-63. PubMed ID: 16970945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
